Latest Redmile Group, LLC Stock Portfolio
Redmile Group, LLC Performance:
2025 Q1: -18.64%YTD: -18.64%2024: -8.16%
Performance for 2025 Q1 is -18.64%, and YTD is -18.64%, and 2024 is -8.16%.
About Redmile Group, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Redmile Group, LLC reported an equity portfolio of $1.1 Billions as of 31 Mar, 2025.
The top stock holdings of Redmile Group, LLC are SRRK, KRYS, FOLD. The fund has invested 13.4% of it's portfolio in SCHOLAR ROCK HLDG CORP and 12.6% of portfolio in KRYSTAL BIOTECH INC.
The fund managers got completely rid off STRYKER CORPORATION (SYK), INTUITIVE SURGICAL INC (ISRG) and ARDELYX INC (ARDX) stocks. They significantly reduced their stock positions in ALLAKOS INC (ALLK), BOSTON SCIENTIFIC CORP (BSX) and PLIANT THERAPEUTICS INC (PLRX). Redmile Group, LLC opened new stock positions in IRHYTHM TECHNOLOGIES INC (IRTC), MASIMO CORP (MASI) and KALARIS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to VENTYX BIOSCIENCES INC (VTYX), SOLID BIOSCIENCES INC (SLDB) and INSULET CORP (PODD).
The top stock holdings of Redmile Group, LLC are SRRK, KRYS, FOLD. The fund has invested 13.4% of it's portfolio in SCHOLAR ROCK HLDG CORP and 12.6% of portfolio in KRYSTAL BIOTECH INC.
The fund managers got completely rid off STRYKER CORPORATION (SYK), INTUITIVE SURGICAL INC (ISRG) and ARDELYX INC (ARDX) stocks. They significantly reduced their stock positions in ALLAKOS INC (ALLK), BOSTON SCIENTIFIC CORP (BSX) and PLIANT THERAPEUTICS INC (PLRX). Redmile Group, LLC opened new stock positions in IRHYTHM TECHNOLOGIES INC (IRTC), MASIMO CORP (MASI) and KALARIS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to VENTYX BIOSCIENCES INC (VTYX), SOLID BIOSCIENCES INC (SLDB) and INSULET CORP (PODD).
Redmile Group, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Redmile Group, LLC made a return of -18.64% in the last quarter. In trailing 12 months, it's portfolio return was -33.24%.
New Buys
| Ticker | $ Bought |
|---|---|
| irhythm technologies inc | 5,950,430 |
| masimo corp | 4,341,930 |
| kalaris therapeutics inc | 666,129 |
New stocks bought by Redmile Group, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ventyx biosciences inc | 1,164 |
| solid biosciences inc | 228 |
| insulet corp | 183 |
| amicus therapeutics inc | 35.14 |
| immunome inc | 11.04 |
| beam therapeutics inc | 5.35 |
| establishment labs hldgs inc | 4.75 |
Additions to existing portfolio by Redmile Group, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| allakos inc | -71.59 |
| boston scientific corp | -38.19 |
| pliant therapeutics inc | -29.08 |
| invivyd inc | -24.13 |
| akero therapeutics inc | -23.96 |
| astria therapeutics inc | -22.29 |
| 4d molecular therapeutics in | -16.68 |
| immunovant inc | -14.24 |
Redmile Group, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| stereotaxis inc | -4,102,780 |
| achilles therapeutics plc | -1,833,220 |
| ardelyx inc | -7,991,630 |
| ac immune sa | -2,792,610 |
| adaptimmune therapeutics plc | -385,497 |
| hookipa pharma inc | -213,816 |
| allovir inc | -801,347 |
| stryker corporation | -11,044,900 |
Redmile Group, LLC got rid off the above stocks
Sector Distribution
Redmile Group, LLC has about 87.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.9 |
| Others | 12 |
Market Cap. Distribution
Redmile Group, LLC has about 2.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 47.5 |
| MID-CAP | 33.7 |
| UNALLOCATED | 14.1 |
| LARGE-CAP | 2.5 |
| MICRO-CAP | 2 |
Stocks belong to which Index?
About 82.1% of the stocks held by Redmile Group, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 79.6 |
| Others | 17.9 |
| S&P 500 | 2.5 |
Redmile Group, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Redmile Group, LLC
Redmile Group, LLC has 56 stocks in it's portfolio. About 61.8% of the portfolio is in top 10 stocks. SRRK proved to be the most loss making stock for the portfolio. KRYS was the most profitable stock for Redmile Group, LLC last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 1.96 | 8,253,320 | 20,715,800 | unchanged | 0.00 | ||
| ACHL | achilles therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADAP | adaptimmune therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADCT | adc therapeutics sa | 2.09 | 15,666,700 | 22,090,100 | unchanged | 0.00 | ||
| ADGI | invivyd inc | 0.13 | 2,285,320 | 1,383,300 | reduced | -24.13 | ||
| AKRO | akero therapeutics inc | 3.59 | 939,277 | 38,021,900 | reduced | -23.96 | ||
| ALLK | allakos inc | 0.02 | 856,615 | 194,966 | reduced | -71.59 | ||
| ALVR | allovir inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALXO | alx oncology hldgs inc | 0.21 | 3,640,830 | 2,268,240 | reduced | -1.32 | ||
| ANNX | annexon inc | 1.15 | 6,300,640 | 12,160,200 | unchanged | 0.00 | ||
| ARDX | ardelyx inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATRA | atara biotherapeutics inc | 0.25 | 441,701 | 2,623,700 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 0.14 | 269,078 | 1,436,880 | reduced | -22.29 | ||
| BEAM | beam therapeutics inc | 2.97 | 1,610,330 | 31,449,700 | added | 5.35 | ||
| BSX | boston scientific corp | 1.84 | 193,283 | 19,498,400 | reduced | -38.19 | ||
| CLDX | celldex therapeutics inc new | 1.01 | 590,175 | 10,711,700 | reduced | -4.16 | ||
| COGT | cogent biosciences inc | 1.82 | 3,216,030 | 19,264,000 | reduced | -9.53 | ||
| CYTK | cytokinetics inc | 0.31 | 82,098 | 3,299,520 | reduced | -11.34 | ||
| ESTA | establishment labs hldgs inc | 1.29 | 335,366 | 13,684,600 | added | 4.75 | ||
| ETNB | 89bio inc | 1.30 | 1,886,440 | 13,714,400 | reduced | -12.95 | ||